Zhuhai Sailong Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.062x

Zhuhai Sailong Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a cash flow conversion efficiency ratio of -0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-28.66 Million ≈ $-4.19 Million USD) by net assets (CN¥460.47 Million ≈ $67.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)

Cash flow conversion efficiency of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025. This chart illustrates how Zhuhai Sailong Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002898 live share price for real-time trading data and today's change.

Zhuhai Sailong Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Zhuhai Sailong Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhuhai Sailong Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhuhai Sailong Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Zhuhai Sailong Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Agrimin Ltd AU:AMN	-0.039x
Clean & Science co. Ltd KQ:045520	0.147x
Kim Hin Joo KLSE:0210	0.223x
Adaptimmune Therapeutics Plc NASDAQ:ADAP	0.490x
Pan Entertainment Co. Ltd KQ:068050	0.057x
RS Public Company Limited BK:RS	-0.029x
ESSA Pharma Inc NASDAQ:EPIX	-0.039x
Investcorp Credit Management BDC Inc NASDAQ:ICMB	0.187x

Annual Cash Flow Conversion Efficiency for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025. Review 002898 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥384.15 Million ≈ $56.21 Million	CN¥19.06 Million ≈ $2.79 Million	0.050x	+163.74%
2024-12-31	CN¥499.28 Million ≈ $73.06 Million	CN¥-38.86 Million ≈ $-5.69 Million	-0.078x	-216.81%
2023-12-31	CN¥535.88 Million ≈ $78.42 Million	CN¥35.71 Million ≈ $5.23 Million	0.067x	+148.30%
2022-12-31	CN¥526.35 Million ≈ $77.02 Million	CN¥14.12 Million ≈ $2.07 Million	0.027x	-57.35%
2021-12-31	CN¥563.66 Million ≈ $82.48 Million	CN¥35.46 Million ≈ $5.19 Million	0.063x	+21040.16%
2020-12-31	CN¥587.00 Million ≈ $85.90 Million	CN¥174.69K ≈ $25.56K	0.000x	+100.42%
2019-12-31	CN¥659.02 Million ≈ $96.44 Million	CN¥-46.52 Million ≈ $-6.81 Million	-0.071x	-1507.08%
2018-12-31	CN¥663.54 Million ≈ $97.10 Million	CN¥3.33 Million ≈ $487.06K	0.005x	-96.35%
2017-12-31	CN¥618.64 Million ≈ $90.53 Million	CN¥85.13 Million ≈ $12.46 Million	0.138x	-55.48%
2016-12-31	CN¥254.45 Million ≈ $37.23 Million	CN¥78.65 Million ≈ $11.51 Million	0.309x	+38.92%
2015-12-31	CN¥213.20 Million ≈ $31.20 Million	CN¥47.44 Million ≈ $6.94 Million	0.223x	-39.11%
2014-12-31	CN¥140.55 Million ≈ $20.57 Million	CN¥51.36 Million ≈ $7.52 Million	0.365x	-36.90%
2013-12-31	CN¥111.97 Million ≈ $16.38 Million	CN¥64.84 Million ≈ $9.49 Million	0.579x	--

About Zhuhai Sailong Pharmaceutical Co Ltd

SHE:002898 China Biotechnology

Market Cap

$9.53 Million

CN¥65.12 Million CNY

Market Cap Rank

#27045 Global

#4745 in China

Share Price

CN¥0.37

Change (1 day)

-2.63%

52-Week Range

CN¥0.32 - CN¥14.65

All Time High

CN¥29.47